A provision of the “Inflation Reduction Act” (IRA) could threaten investments in "small molecule" drug development, said the head of the Pasadena-based Pacific Research Institute (PRI).
There were six companies in cities associated with San Mateo County that received seven FDA inspections in the fourth quarter of 2023, according to the U.S. Food and Drug Association.